awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37924275-23654EB5-8146-4F59-B7A9-C6E5A7B69E24
Q37924275-23654EB5-8146-4F59-B7A9-C6E5A7B69E24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37924275-23654EB5-8146-4F59-B7A9-C6E5A7B69E24
Is the large simple trial design used for comparative, post-approval safety research? A review of a clinical trials registry and the published literature.
P2860
Q37924275-23654EB5-8146-4F59-B7A9-C6E5A7B69E24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37924275-23654EB5-8146-4F59-B7A9-C6E5A7B69E24
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9aca9308f2a23e370807dc81c421e2e93dce251
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti